Back
Crinetics Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
60
CRNX
Crinetics Pharmaceuticals
Last Price:
59.56
Seasonality Move:
9.3%
Sell
40
NBY
NovaBay Pharmaceuticals
Last Price:
0.71
Seasonality Move:
-7.72%
Buy
60
Crinetics Pharmaceuticals (CRNX)
is a Buy
Is Crinetics Pharmaceuticals a Buy, Sell or Hold?
- The current Crinetics Pharmaceuticals [CRNX] share price is $58.92. The Score for CRNX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- CRNX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals's stock price today?
-
The Crinetics Pharmaceuticals share price today is $58.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.71
The current trend is relatively stagnant and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
CRNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.35 | Buy |
| Relative Strength Index (14 RSI): | 58.51 | Buy |
| Chaikin Money Flow: | -780726 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.69 - 59.83) | Buy |
| Bollinger Bands (100): | (48.73 - 56.63) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 53.84 | Buy |
| Chaikin Money Flow: | -257778 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.59 - 0.73) | Buy |
| Bollinger Bands (100): | (0.28 - 1.62) | Sell |
CRNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.99 | Sell |
| 20-day SMA: | 58.26 | Buy |
| 50-day SMA: | 54.58 | Buy |
| 200-day SMA: | 48.24 | Buy |
| 8-day EMA: | 58.88 | Buy |
| 20-day EMA: | 57.69 | Buy |
| 50-day EMA: | 55.44 | Buy |
| 200-day EMA: | 47.9 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.73 | Sell |
| 20-day SMA: | 0.67 | Buy |
| 50-day SMA: | 0.63 | Buy |
| 200-day SMA: | 2.49 | Sell |
| 8-day EMA: | 0.72 | Sell |
| 20-day EMA: | 0.69 | Buy |
| 50-day EMA: | 0.74 | Sell |
| 200-day EMA: | 5.92 | Sell |
Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.21 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Crinetics Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||